Scientific Presentations by NCTR Researchers — Imaging, Nanotechnology, Drug Safety - NCTR Research Highlights

NCTR Research Highlights
Scientific Presentations by NCTR Researchers — Imaging, Nanotechnology, Drug Safety

Three FDA scientists presented views at the December 1-2, 2009, Health and Environmental Sciences Institute (HESI)-sponsored workshop,"Translational Imaging in Preclinical Safety Assessment and Environmental Hazard Identification." Dr. William Slikker, National Center for Toxicological Research Center Director, presented an address titled, "In Vivo Detection of Neuroapoptosis During Development." Drs. Laniyonu and Goodsaid from FDA's Center for Drug Evaluation and Research addressed the issues of regulatory challenges and qualification of biomarkers, respectively.

Dr. William Slikker presented the plenary lecture, "Nanotechnology: Pharmacological Applications and Approaches to Safety Assessment," at the annual meeting of the Argentina Society of Pharmacology on November 24, 2009.

Dr. Weida Tong was the keynote speaker at the Drug Non-Clinical Safety Academic conference held December 2-4, 2009, in Beijing, China and was also the keynote speaker at the Systems Biology and Safety Assessment Conference held December 5-9, 2009, in Hangzhou, China. Dr. Tong will hold further discussions at the MicroArray Quality Control III (MAQC-III) meetings in Shanghai, China, December 10-11, 2009.

For further information, contact Dr. William Slikker, Jr., Director, NCTR.

abrir aquí para acceder a los documentos FDA:
NCTR Research Highlights